ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentContoneGRG Gene Technology SA
GRG Gene Technology SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of GRG Gene Technology is the development of innovative therapeutic strategies for cardiovascular diseases through the application of plant biotechnology to human health. In particular, the company focuses on the development of anti-atherogenic APOA-1 mutants that can be administered in a safe and cost-effective manner to deliver optimal doses of the active ingredient.

AI-generated
Offering

Products & services

Industry:Research & Development
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
No score yet

GRG Gene Technology SA

Pharmaceutical Industry
✓ Offered3
Research and development in plant biotechnology for cardiovascular therapies
Research and development of innovative therapeutic strategies for cardiovascular diseases, using plant biotechnology applied to human health and preclinical testing of therapeutic products.
Delivery system for therapeutic biological macromolecules
Innovative synthesis and delivery system for biological macromolecules with therapeutic potential, designed to overcome limitations in synthesis, purification and drug delivery.
APOA-1 anti-atherogenic muteins in rice-milk
Therapeutic products based on APOA-1 anti-atherogenic muteins, formulated with a production and delivery system in rice-milk for atherosclerosis and other diseases.
Trust & reputation

ranQ Trust Score of GRG Gene Technology SA

Trust Score

No score yet

x

A published score requires a data basis of at least 50% and data from at least two criteria groups other than identity. Missing evidence: Review quality, Review volume, Review recency, Media authority

Data basis 54% · As of October 2026

GRG Gene Technology SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
GRG Gene Technology SA scores 82.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.92.512%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
GRG Gene Technology SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
GRG Gene Technology SA scores 0.0 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.0.04%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%

The data basis is 54%, below the threshold at which ranQ publishes a score. Evidence is missing for: Review quality, Review volume, Review recency, Media authority. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once GRG Gene Technology SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

GRG Gene Technology SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank GRG Gene Technology SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of GRG Gene Technology SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Via Cantonale 29
6594 Contone

At a glance

Legal form
Corporation
UID
CHE-425.079.072
Founded
2014 · 12 years
Last commercial register change
March 19, 2024
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    SS
    SOLS SA
    Chiasso
    FS
    FEMTOprint SA
    Agno
    BD
    Blockchain District SA
    Lugano
    BS
    Budokan Sagl
    Stabio
    SS
    Swiss Stem Cell Foundation
    Lugano
    MR
    MA R&D Sagl
    Minusio
    AF
    Alpine Foundation for Life Sciences
    Olivone
    XS
    XR Solution Sagl
    Manno